1. Doudna JA, Charpentier E. The new frontier of genome engineering with CRISPR-Cas9. Science. 2014;346(6213):1258096.

2. Human genome editing [Available from: https://www.who.int/health-topics/human-genome-editing#tab=tab_1.

3. Harris J. Enhancing evolution: The ethical case for making better people. 2010.

4. The Holy Quran, Translated by: Naser Makarem Shirazi. Tehran: Dar al-Quran Publication; 2017.

5. Tabatabaei MH. al-Mizan fi Tafsir al-Quran. Qom: Islamic Publications Office; 1996. (Full Text in Persian)

6. Tabarsi F. Majma’ al-Bayan fi Tafsir al-Quran. Tehran: Nasser Khosrow Publications; 1993. (Full Text in Persian)

7. Sadler TW. Langman's medical embryology: Lippincott Williams & Wilkins; 2018.

8. Moore KL, Persaud TVN, Torchia MG. The developing human: clinically oriented embryology: Elsevier Brasil; 2020.

9. Carlson BM. Human embryology and developmental biology: Elsevier Health Sciences; 2018.

10. Khorrami F, Bostan N, Yousefi Labani J, Moradi SY. The effectiveness of mindfulness on students’ resilience. The Journal of New Advances in Behavioral Sciences. 2019;24(32):61-75. (Full Text in Persian)

11. Izutsu T. Ethico-Religious Concepts in the Qur'an, Translation by Badrei F. Tehran: Farzan Rooz; 2015.

12. Green RM. Babies by design: The ethics of genetic choice: Yale University Press; 2007.

13. WHO Expert Advisory Committee on Developing Global Standards for Governance and Oversight of Human Genome Editing. Human Genome Editing [Available from: https://www.who.int/publications/b/58764.

14. Rodriguez E. Ethical issues in genome editing using Crispr/Cas9 system. Journal of Clinical Research and Bioethics. 2016;7(2).

15. Memi F, Ntokou A, Papangeli I, editors. CRISPR/Cas9 gene-editing: Research technologies, clinical applications and ethical considerations. Seminars in perinatology; 2018: Elsevier.

16. Alamdari M. Honesty in Behavior Beyond the Complexity of Human Interactions. 2024 [Available from: https://en.civilica.com/note/9150/. (Full Text in Persian)

17. Shinwari ZK, Tanveer F, Khalil AT. Ethical issues regarding CRISPR mediated genome editing. Current issues in molecular biology. 2018;26(1):103-10.

18. Mo O. CRISPR-Cas9 human genome editing: challenges, ethical concerns and implications. Journal of Clinical Research and Bioethics. 2015;6(6).

19. Ayanoğlu FB, Elçin AE, Elçin YM. Bioethical issues in genome editing by CRISPR-Cas9 technology. Turkish Journal of Biology. 2020;44(2):110-20.

20. Majlisi MB. Bihar al-Anwar. Beirut: Maktab al-Wafa Publications; 1983. (Full Text in Persian)

21. Mosavi Khomeini SR. Tahrir al-wasilah. Teharan: Institute for Compilation and Publication of Imam Khomeini's Works; 1965. (Full Text in Persian)

22. Kulayni M. al-Kafi. Tehran: Dar al-Kutb al-Islamiyah; 2009. (Full Text in Persian)

23. Khoei A. The document in the description of al-Arwa al-Wathqi. Qom: Lotfi Publications; 2004. (Full Text in Persian)

24. Ansari M. Fiqh Letters (for Sheikh Ansari). Qom: Majmaal al-Fikr al-Islami Publications; 2025. (Full Text in Persian)

25. Makarem Shirazi N. al-Qavaed al-Fiqhiyah. Qom: Imam Ali Ibn Abi Talib School Publications; 1991.

26. Yaghoobi H, Safaei M, Shojaeian A, Sanami S. Ethical Issues in Genome Editing and Gene Therapy with Emphasizing on CRISPR-Cas System. Journal of Medical Ethics and History of Medicine. 2019;12(1):349-60. (Full Text in Persian)

27. [Available from: https://www.makarem.ir/#1548;.

28. Najafi Javaheri MH. Jawahir al-Kalam. Beirut: Dar al-Ihya al-Turaht al-Arabi Publications; 1983. (Full Text in Arabic)

29. Marmot M. The influence of social and economic determinants on health. In: Marmot M WR, editors. Social Determinants of Health. 2nd ed. Oxford: Oxford University Press; 2006. p. 19–44.

30. Ameli M. al-Qavaid va al-Favaid. Qom: Mofid Publications; 1999. (Full Text in Persian)

31. Naraqi A. The Return of Days in the Explanation of the Rules of the Laws. 1949.

32. al-Hurr al-Amil M. Wasa’il Al-Shi’ah. Qom: Al-Al-Bayt Publications. 1993. (Full Text in Persian)

33. Newman JH. The idea of a university. London: Longman; 1852.

34. Waltz M, Walker RL, Flatt MA, MacKay D, Conley JM, Juengst ET, et al. Challenging the boundaries between treatment, prevention, and enhancement in human genome editing. The CRISPR Journal. 2024;7(4):180-7.

35. Motahari M. Collection of Works. 2 ed. Tehran: Sadra Publications; 2011. (Full Text in Persian)

36. Ghazanfarpour SM, Mandali M. Jurisprudential Issues Regarding Genetic Medicine and Gene Modification2025.

37. Makaram Shirazi M. Hoqhuqh-e Bashar dar Islam. Qom: Daftar Neshar Fareang Eslami; 2019. (Full Text in Persian)

38. Berry RM. The ethics of genetic engineering: Routledge; 2013.

39. Beauchamp TL, Childress JF. Principles of biomedical ethics: Edicoes Loyola; 1994.

40. Godarzi B. Nazarieh Hoqhuqh Janin dar Feqh-e Shi'e. Qom: Entesharat Daneshgah Qhom; 2002. (Full Text in Persian)

41. Sandel MJ. The case against perfection: Ethics in the age of genetic engineering: Harvard university press; 2007.

42. Tabatabayi Yazdi M. Oravat al-Wosgha. Qom: Moaseseh Al-nashr al-Islami; 1996. (Full Text in Persian)

43. Sobhani M. Nazarieh-pardazi dar Feqh-e Pezeshki-e Novin. Taharan: Gorooh Fagheh Pezeshki; 2016. (Full Text in Persian)

44. Poli L. Human germline genome editing and human rights law: A “brave new world” is not here to come. BioLaw Journal. 2021:359-68.

45. Goberna MF, Lezcano EG, Castro Alegría A, Nara Pereira E, Quintana SA, Arrúa AA, et al. Genome editing between wonder and rejection. Frontiers in Bioengineering and Biotechnology. 2026;14:1832039.

46. Javadi Amoli A. Velayat-e Faghih-Velayat-e Ensan-e Kamel. Ghom: Asra; 2016. (Full Text in Persian)

47. Ginghină S. Principles of biomedical ethics. Logos Universality Mentality Education Novelty Section Social Sciences. 2023;12(2):110-22.

48. National Academies of Sciences, Engineering, and Medicine; National Academy of Medicine; National Academy of Sciences; Committee on Human Gene Editing: Scientific, Medical, and Ethical Considerations. Human Genome Editing: Science, Ethics, and Governance. Washington (DC): National Academies Press (US); 2017 Feb 14. PMID: 28796468.